|
(13R,14S)-dihydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate
(2E)-3-methylhex-2-enoate
(2R)-2-[(1R)-1-hydroxy-12-\{2-[14-(2-icosylcyclopropyl)tetradecyl]cyclopropyl\}dodecyl]hexacosanoate
(2R)-2-[(1R)-1-hydroxy-14-\{2-[14-(2-icosylcyclopropyl)tetradecyl]cyclopropyl\}tetradecyl]hexacosanoate
(2R)-2-[(1R)-1-hydroxy-18-\{2-[10-(2-icosylcyclopropyl)decyl]cyclopropyl\}octadecyl]hexacosanoate
(2R)-2-[(1R)-1-hydroxy-18-\{2-[10-(2-nonadecylcyclopropyl)decyl]cyclopropyl\}octadecyl]hexacosanoate
(2R)-2-[(1R)-1-hydroxy-18-\{2-[10-(2-octadecylcyclopropyl)decyl]cyclopropyl\}octadecyl]hexacosanoate
(2R)-2-[(1R)-1-hydroxy-18-\{2-[10-(2-octadecylcyclopropyl)decyl]cyclopropyl\}octadecyl]tetracosanoate
(2R)-2-[(1R)-1-hydroxy-20-\{2-[10-(2-icosylcyclopropyl)decyl]cyclopropyl\}icosyl]hexacosanoate
(2R)-2-[(1R)-1-hydroxy-20-\{2-[10-(2-nonadecylcyclopropyl)decyl]cyclopropyl\}icosyl]hexacosanoate
(2R)-2-[(1R)-1-hydroxy-20-\{2-[10-(2-octadecylcyclopropyl)decyl]cyclopropyl\}icosyl]hexacosanoate
(2R)-2-[(1R)-1-hydroxy-20-\{2-[10-(2-octadecylcyclopropyl)decyl]cyclopropyl\}icosyl]tetracosanoate
(2R)-2-[(1R)-1-hydroxy-22-\{2-[10-(2-octadecylcyclopropyl)decyl]cyclopropyl\}docosyl]hexacosanoate
(2R)-2-[(1R)-14-\{2-[(15Z)-hexatriacont-15-en-1-yl]cyclopropyl\}-1-hydroxytetradecyl]hexacosanoate
(4Z,7Z,10Z,14E,16Z,19Z)-13-hydroxydocosahexaenoate
(5Z,11Z,14Z)-8,9-dihydroxyicosatrienoate +
(6Z,8E,10E,14Z,16E,18R)-5,12,18-trihydroxyicosapentaenoate
(7E,9E,11Z,13E,15R,17Z)-5,6,15-trihydroxyicosapentaenoate
(7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoate
(8E,10S)-10-hydroxy-8-octadecenoate
(9S,10R)-dihydroxyoctadecanoate
(9Z)-16-hydroxyhexadec-9-enoate
(9Z)-17-hydroxyoctadec-9-enoate 17-O-beta-D-glucoside
(9Z)-17-hydroxyoctadec-9-enoate 17-O-sophoroside
(omega-1)-hydroxy fatty acid anion +
(S,S)-9,10-dihydroxyoctadecanoate
11,12-epoxy-20-hydroxy-(5Z,8Z,14Z)-icosatrienoate
11-hydroxy-(12S,13S)-epoxy-(9Z)-octadecenoate(1-)
13,14-dihydro-15-oxolipoxin A4(1-)
13,14-dihydrolipoxin A4(1-)
14,15-epoxy-20-hydroxy-(5Z,8Z,11Z)-icosatrienoate
18-hydroxycarbocyclic thromboxane A2(1-)
2-hydroxy fatty acid anion +
2-methyl-3-hydroxybutyrate +
2R-2-[(1R)-1-hydroxy-16-\{2-[10-(2-octadecylcyclopropyl)decyl]cyclopropyl\}hexadecyl]hexacosanoate
3,16-dihydroxyhexadecanoate
3-hydroxy fatty acid anion +
4-hydroxy-2-oxohexanoate +
5(S),6(S)-epoxy-18-hydroxy-(7E,9E,11Z,14Z,16E)-icosapentaenoate +
5,6-epoxy-20-hydroxy-(8Z,11Z,14Z)-icosatrienoate
5-hydroperoxy-15-HETE(1-) +
6-hydroxy-3,7-dimethyloctanoate +
6-hydroxy-3-isopropenylheptanoate +
6-trans-leukotriene B4(1-) +
7,8-epoxy,17-hydroxy-(9E,11E,13Z,15E,19Z)-docosapentaenoate
8,9-epoxy-20-hydroxy-(5Z,11Z,14Z)-icosatrienoate
carbocyclic thromboxane A2(1-) +
hydroperoxyoctadecenoate +
hydroxy monounsaturated fatty acid anion + Any monounsaturated fatty acid anion carrying one or more hydroxy substituents.
hydroxy polyunsaturated fatty acid anion +
hydroxy saturated fatty acid anion +
omega-hydroxy fatty acid anion +
|
|